The Wegovy pill’s ‘surprise miss’ is one reason Novo Nordisk’s stock is down

The Danish drugmaker also revealed an improved outlook for the year.

Novo outlook hike falls flat as high Wegovy pill hopes unmet  Reuters

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance  wsj.com

The Danish drugmaker's Wegovy pill has exceeded 5 million prescriptions in the U.S. since launch, driving stronger-than-expected profit

TKO Group, the home of UFC and WWE, saw revenue jump 18% to $1.5 billion for the three months ended in June, beating Wall Street estimates. The stock, which has been taking its knocks this year, jumped in late trading after the earnings report, which included higher forecasts for 2026 full-year revenue and adjusted ebi